Regulations requiring patient-specific prescriptions (PSPs) for drugs used off-label may have caused a drop in prescriptions for intravitreal bevacizumab, with retinal specialists switching to medications that don’t require PSPs, according to a study f…
Uncategorized
Study finds 5% incidence of IOL opacification after DSEK
IOL opacification was identified in 5% of eyes that underwent Descemet’s stripping endothelial keratoplasty, according to one study.Investigators retrospectively analyzed the records of 160 pseudophakic eyes that underwent DSEK between 2003 and 2013. They assessed the interval between DSEK and diagnosis of IOL opacification, Snellen corrected distance visual acuity before and after opacification, IOL specifications and incidence of IOL exchange.
A Tale Of Two ACA Co-Ops: One Standing, One Falling
(MedPage Today) — The performance of the co-op insurers has been a mixed bag
Uncategorized
Phase 3 clinical trial enrollment begins for ocular allergy drug
Enrollment is underway for a second phase 3 clinical trial of Dextenza sustained release dexamethasone for treatment of allergic conjunctivitis, according to a press release from Ocular Therapeutix.The prospective, randomized, double-masked, vehicle co…
Uncategorized
Omeros reports $3.3 million in revenue in third quarter
Omeros reported $3.3 million in revenue in the third quarter, which includes $3.2 million in Omidria sales, according to a press release. The company reported $214,000 in revenue in the third quarter of 2014.
Uncategorized
Inaugural Retina World Congress Will Convene in Spring 2017
SAN DIEGO–(BUSINESS WIRE)–The inaugural Retina World Congress will be held February 23-26, 2017, at the Fort Lauderdale Marriott, Florida. Program will feature scientific presentations and medical education courses.